Fitlife Brands (FTLF) risk factors, FY2024 10-K

Risks Relating to our Business and Industry

1. 01We face significant competition in the markets in which we compete. If we are not able to compete effectively, we may not be able to increase sales or maintain profitability
2. 02A substantial portion of our revenue is from sales of products on Amazon’s U.S. Marketplace and any change, limitation or restriction on our ability to operate on Amazon’s platform could have a material adverse effect on our business, results of operations, financial condition and prospects
3. 03We are currently dependent on sales to GNC for a significant portion of our sales
4. 04Loss of, a significant reduction of purchases by, or bankruptcy of a major distribution partner or customer, may adversely affect our business, financial condition, results of operations and cash flows
5. 05We must identify changing consumer and customer preferences and behaviors and develop and offer products to meet these preferences
6. 06Our intellectual property rights are valuable and any inability to protect them could reduce the value of our products and brands and have a material adverse effect on our business
7. 07Our results may be adversely impacted if consumers do not maintain favorable perceptions of our brands
8. 08Our sales and profit growth are dependent upon our ability to expand existing market penetration and enter into new markets
9. 09Adverse publicity associated with our products, ingredients, or those of similar companies, could adversely affect our sales and revenue
10. 10The efficacy of nutritional supplement products is supported by limited conclusive clinical studies, which could result in reduced market acceptance of these products and lower revenue or lower revenue growth rates
11. 11If the products we sell do not have the healthful effects intended, our business may suffer
12. 12A slower growth rate in the nutritional supplement industry could lead to reduced revenue or make it more difficult for us to sustain consistent revenue growth
13. 13Future outbreaks of COVID-19 or other illnesses could have a material adverse impact on us in the future
14. 14Our success depends on the experience and skill of our chief executive officer and key personnel, whom we may not be able to retain and we may not be able to hire enough additional personnel to meet our needs

Financial and Economic Risks

1. 15We may not be able to effectively manage our growth, which could materially harm our business, financial condition, results of operations and cash flows
2. 16Unfavorable economic conditions, including high inflation, recessions and other macroeconomic conditions or trends may have an adverse impact on our business, financial results, and prospects
3. 17Trade policies, treaties and tariffs could have a material adverse effect on our business
4. 18We may incur substantial debt in conjunction with our M&A strategy, which could have a negative impact on our liquidity position and which could adversely affect our business
5. 19The agreements governing our current and potential future indebtedness may contain various covenants that limit our ability to take certain actions and also require us to meet financial maintenance tests, and failure to comply with these covenants could have a material adverse effect on us
6. 20To service indebtedness and fund other cash needs, we will require a significant amount of cash. Our ability to generate cash depends on many factors beyond our control
7. 21Increases in interest rates may negatively affect our earnings
8. 22Impairment in the carrying value of intangible assets could negatively impact our financial condition and results of operations. If our goodwill or other intangible assets become impaired, we will be required to record impairment charges, which may be significant
9. 23Unsuccessful implementation of business strategies to reduce costs, or unintended consequences of the implementation of such strategies, may adversely affect our business, financial condition, results of operations and cash flows

Legal and Regulatory Risks

1. 24We are affected by extensive laws, governmental regulations, administrative determinations, court decisions and similar constraints, which can make compliance costly and subject us to enforcement actions by governmental agencies
2. 25We are dependent on our third-party manufacturers to supply our products in the compositions we require, and we do not independently analyze each production lot of our products. Any errors in our product manufacturing could result in product recalls, significant legal exposure, and reduced revenue
3. 26Certain of our products are subject to a higher level of regulatory scrutiny, resulting in increased costs of operations and the potential for delays in product sales
4. 27Pending and future litigation and claims may impair our reputation or lead us to incur significant costs
5. 28Our products may not meet health and safety standards or could become contaminated
6. 29If our products become contaminated or adulterated, or if they are misbranded or mislabeled, we might need to recall or withdraw those items and we may experience product liability claims
7. 30If we pursue additional acquisitions or other strategic transactions, we may not be able to successfully consummate favorable transactions or successfully integrate acquired businesses
8. 31If we fail to comply with the continued listing requirements of the Nasdaq Capital Market, our Common Stock may be delisted and the price of our Common Stock and our ability to access the capital markets could be negatively impacted
9. 32The price of our securities could be subject to wide fluctuations and your investment could decline in value
10. 33We may issue Preferred Stock with rights senior to the Common Stock
11. 34You should not rely on an investment in our Common Stock for the payment of cash dividends
12. 35Our Chair of the Board of Directors, Chief Executive Officer and significant shareholder may have certain personal interests that may affect the Company
13. 36Compliance with changing corporate governance regulations and public disclosures may result in additional risks and exposures